Clinical Trial: Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07067775) titled 'Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers' on July 07.

Brief Summary: This clinical study will adopt an open-label, randomized, two-crossover design to explore the pharmacokinetic and pharmacodynamic profiles of Vicagrel Capsules and Clopidogrel Tablets in Healthy Subjects with CYP2C19 Normal Metabolizers

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Acute Coronary Syndrome

Intervention: DRUG: Vicagrel Capsules

Vicagrel Capsules qd per period, for two periods

DRUG: Clopidogrel Tablets

Clopidogrel Tablets qd per period, for two ...